Summary
Enprofylline is a novel xanthine derivative with negligible adenosine antagonizing ability. It is eliminated almost exclusively by renal clearance with a half-life of about 2 h. Three i.v. infusions of enprofylline (1 mg/kg body weight over 10 min) were given at hourly intervals to 16 patients with stable, reversible airway obstruction. The patients were pretreated at random with i.v. terbutaline (4 µg/kg body weight) or placebo according to a double blind cross-over design. Lung function and drug concentrations in plasma were followed. Enprofylline produced significant and concentration-dependent bronchodilatation between plasma levels of 1.24 and 3.22 mg/l. The improvement in ventilatory function was significantly enhanced by terbutaline pretreatment. At the highest plasma levels of enprofylline nausea and headache were found as subjective side effects. The results suggest that enprofylline and terbutaline might best be used in a low dose combination in the treatment of bronchial asthma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Billing B, Dahlqvist R, Garle M, Hörnblad Y, Ripe E (1982) Separate and combined use of terbutaline and theophylline in asthmatics. Effects related to plasma levels. Eur J Respir Dis 63: 399–409
Borgå O, Andersson K-E, Edholm L-E, Fagerström P-O, Lunell E, Persson CGA (1984) Enprofylline kinetics in healthy subjects after single doses. Clin Pharmacol Ther 34: 799–804
Conradson TB (1984) Cardiovascular effects of two different xanthines in healthy subjects. Studies at rest, during exercise and in combination with a beta-agonist, terbutaline. Eur J Pharmacol 27: 319–324
Jenne JW, (1981) A critique of dosing strategies for beta2-adrenergic agents and theophylline. Lung 159: 295–314
Laursen LC, Johannesson N, Dirksen A, Djurup R, Munch EP, Taudorf E, Weeke B (1983) Enprofylline — effects of a new bronchodilating xanthine derivative in asthmatic patients. Allergy 38: 75–79
Lunell E, Andersson K-E, Persson CGA (1983) Tolerance and some circulatory effects of intravenous and oral enprofylline in healthy volunteers. Acta Pharmacol Toxicol 53: 205–211
Lunell E, Andersson K-E, Persson CGA, Svedmyr N (1984) Intravenous enprofylline in asthma patients. Eur J Respir Dis 65: 28–34
Morris JF, Koski A, Johnson LC (1971) Spirometric standards for healthy non smoking adults. Am Rev Respir Dis 103: 57–67
Persson CGA (1982) Xanthines for asthma — present status. Trend Pharmacol Sci 3: 312–313
Persson CGA, Gustafsson B (1986) Tracheal relaxation from combinations of xanthines and of a β-receptor agonist and xanthines. Lung 164: 33–40
Svedmyr N, Svedmyr K (1979) Combined effects of theophylline and beta2-adrenoceptor stimulants in asthmatics. Curr Med Res Opin 6 [Suppl 6]: 77–83
Wolfe JD, Tashkin DP, Calvarese B, Simmons M (1978) Bronchodilator effects of terbutaline and aminophylline alone and in combination in asthmatic patients. N Engl J Med 298: 363–367
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rasmussen, J.B., Lunell, E. Additive bronchodilator effects of terbutaline and enprofylline in asthma. Eur J Clin Pharmacol 32, 23–26 (1987). https://doi.org/10.1007/BF00609953
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00609953